Levodopa-induced dyskinesia comes from dopamine arriving in spikes that the brain can no longer absorb, and it shows up as involuntary jerking or writhing. It usually shows up after four to ten years of treatment. By then, Parkinson’s has destroyed most of the neurons that stored dopamine, so the brain can’t hold a dose in reserve. Each tablet arrives as a spike. Roughly four in ten long-term users get it, and relatives tend to notice before the patient does.
According to Dr. Gurneet Singh Sawhney, neurosurgeon in mumbai, patients assume dyskinesia means the drug has failed, but it’s the brain that has lost its ability to even out each dose.
Involuntary movements worsening on your Parkinson’s medication?
What Triggers Dyskinesia In The Brain?
So the issue isn’t total dopamine. It’s the peaks.
Dyskinesia treatment begins with a diary of when the movements start and stop relative to each dose.
Who Is Most Likely To Develop It?
Plenty of patients never get it, and nobody can predict which ones.
Duration: The window typically opens four to ten years into treatment, which is why it’s rare in the first couple of years and likelier the longer someone stays on levodopa.
Dose: Higher doses raise the odds, so most neurologists stay at the lowest dose that controls symptoms, even when a bigger one would feel easier in the short term.
Age at onset: Diagnosis in the forties carries the highest risk because those patients take levodopa for decades, often at rising doses as the disease advances.
Surgical options: DBS surgery becomes the next step when dyskinesia stays disabling despite medication changes, and it usually lets the levodopa dose come down as well.
But none of this guarantees anything, and two patients with matching histories can end up miles apart. Biology doesn’t follow the chart.
A closer look at levodopa therapy next to the surgical options shows what each can and can’t do.
How Is Levodopa-Induced Dyskinesia Managed?
Dyskinesia doesn’t mean levodopa has to stop. It means the delivery needs to change, and there’s a structured sequence before surgery enters the conversation.
Dose Adjustment: Smaller doses given more frequently flatten the concentration peaks that trigger involuntary movements. This alone resolves dyskinesia in some patients without adding any new medication.
Amantadine: The only oral medication with consistent dyskinesia-specific evidence. Extended-release formulations are now preferred over the immediate-release version for better tolerability in long-term use.
Extended-Release Levodopa: More continuous dopamine delivery reduces peak spikes without requiring dose cuts that worsen motor control. Most useful when dyskinesia is strictly peak-dose related.
Surgical Escalation: When adjustments and amantadine haven’t held the line, Parkinson’s surgery is the next step. Subthalamic stimulation allows a 30 to 50 percent levodopa reduction that medication management alone can’t safely achieve.
Most patients go through at least two medication adjustments before a surgical conversation starts. That sequence matters.
What Is Deep Brain Stimulation for Parkinson’s Disease? explains how DBS reduces dyskinesia through levodopa dose reduction and what the surgical process involves.
Frequently Asked Questions
How long does levodopa take to cause dyskinesia?
Usually between four and ten years in.
Is levodopa-induced dyskinesia dangerous?
Not usually, though bad cases make eating and walking hard.
Can lowering the levodopa dose reverse dyskinesia?
Often yes, but stiffness comes back, so it’s a trade.
Does deep brain stimulation help dyskinesia?
It frequently does, and it usually lets patients take less levodopa as well.
Disclaimer: The information shared in this content is for educational purposes only and not for promotional use.